Suppr超能文献

导致儿童原发性硬化性胆管炎和自身免疫性慢性活动性肝炎自身免疫的不同免疫机制。

Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood.

作者信息

Mieli-Vergani G, Lobo-Yeo A, McFarlane B M, McFarlane I G, Mowat A P, Vergani D

机构信息

Department of Child Health, King's College School of Medicine and Dentistry, King's College Hospital, London, England.

出版信息

Hepatology. 1989 Feb;9(2):198-203. doi: 10.1002/hep.1840090206.

Abstract

Children with primary sclerosing cholangitis or autoimmune chronic active hepatitis have similar high levels of immunoglobulin G and non-organ-specific autoantibodies and may have similar histological features. To investigate a possible immunopathogenesis of primary sclerosing cholangitis, we have studied a series of regulatory and/or effector immune mechanisms in eight children with primary sclerosing cholangitis, comparing them to 14 children with autoimmune chronic active hepatitis and 24 healthy children as controls. Antibodies to a liver membrane protein preparation were found in all children with autoimmune chronic active hepatitis tested and in seven of eight with primary sclerosing cholangitis, whereas antibodies against the hepatic asialoglycoprotein receptor were present in three of six patients with autoimmune chronic active hepatitis and in two of the eight with primary sclerosing cholangitis. Lymphocyte cytotoxicity values to autologous hepatocytes were similarly elevated in primary sclerosing cholangitis (median: 50%; range: 38 to 83%) and in autoimmune chronic active hepatitis (median: 52%; range 37 to 87%) compared to controls (median: 8%; range: 0 to 27%) (p less than 0.01 for both). In contrast, T suppressor cell number and function were normal in patients with primary sclerosing cholangitis (median: 23%; range: 19 to 28%; and median: 54%; range: 44 to 61%), but significantly decreased in patients with autoimmune chronic active hepatitis (median: 15%; range: 9 to 21%; and median: 9%; range: -40 to +21%) when compared to controls (median: 24%; range: 16 to 29%; and median: 53%; range: 8 to 77%) (p less than 0.01 for both).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

原发性硬化性胆管炎或自身免疫性慢性活动性肝炎患儿的免疫球蛋白G和非器官特异性自身抗体水平同样很高,且可能具有相似的组织学特征。为研究原发性硬化性胆管炎可能的免疫发病机制,我们对8例原发性硬化性胆管炎患儿的一系列调节和/或效应免疫机制进行了研究,并将他们与14例自身免疫性慢性活动性肝炎患儿及24例健康儿童(作为对照)进行比较。在所有接受检测的自身免疫性慢性活动性肝炎患儿及8例原发性硬化性胆管炎患儿中的7例中发现了针对肝细胞膜蛋白制剂的抗体,而在6例自身免疫性慢性活动性肝炎患者中的3例及8例原发性硬化性胆管炎患者中的2例中存在抗肝去唾液酸糖蛋白受体抗体。与对照组(中位数:8%;范围:0至27%)相比,原发性硬化性胆管炎(中位数:50%;范围:38至83%)和自身免疫性慢性活动性肝炎(中位数:52%;范围37至87%)中对自体肝细胞的淋巴细胞细胞毒性值同样升高(两者p均小于0.01)。相比之下,原发性硬化性胆管炎患者的T抑制细胞数量和功能正常(中位数:23%;范围:19至28%;中位数:54%;范围:44至61%),但与对照组(中位数:24%;范围:16至29%;中位数:53%;范围:8至77%)相比,自身免疫性慢性活动性肝炎患者的T抑制细胞数量和功能显著降低(中位数:15%;范围:9至21%;中位数:9%;范围:-40至+21%)(两者p均小于0.01)。(摘要截选至250词)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验